Clinical trial · Observational
Dosimetric Evaluation of Breathing Impact on PTV and Adjacent Organ At Risk in Breast Cancer Radiotherapy
Dosimetric Evaluation of Breathing Impact on Planning Treatment Volumne and Adjacent Organ At Risk in Breast Cancer Radiotherapy
NCT07048639CI-TRIAL-00091681active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study is likely an observational study, possibly retrospective or prospective, involving patients with breast cancer undergoing radiotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 4D-CT (Four-Dimensional Computed Tomography) | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- 4D-CT (Four-Dimensional Computed Tomography)
- interventionNames
- Diagnostic Test: 4D-CT (Four-Dimensional Computed Tomography)
Primary outcomes (1)
- measure
- Physician's Global Assessment (PGA) Scale with scoring details
- timeFrame
- 12 Months
- description
- The Physician's Global Assessment (PGA) scale is a tool used by physicians to evaluate the overall severity of a patient's disease. It's a subjective assessment, typically on a scale of 0 to 3 or 0 to 4, with higher scores indicating more severe disease activity. The PGA focuses on the overall disease activity, considering both the severity of active manifestations and relevant laboratory results, excluding organ damage and subjective findings unrelated to disease activity.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 25 Years
- Maximum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * Patient of breast cancer. * age 25-40 Exclusion Criteria: * Patients without breast cancer
References
Publications (0)
Data not yet available
No reference posted for this study.